|
Lenvatinib tablet Clinical Trials
1 actively recruiting trial across 1 location
Also known as: Lenvima
Philadelphia, Pennsylvania1 trial
Neoadjuvant Pembrolizumab and Lenvatinib for Renal Cell Carcinoma
Abramson Cancer Center at University of Pennsylvania
Early 1
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.